drugset / Trial / NCT01476449
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to see whether treating diabetic retinal swelling with ranibizumab injections into the eye monthly is better than treating diabetic retinal swelling with ranibizumab injections into the eye less frequently.
Timeline
- Start
- 2011-11
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |